483.21 0.00 (0.00%)
After hours: 4:43PM EDT
|Bid||480.03 x 1800|
|Ask||486.07 x 900|
|Day's Range||482.16 - 489.59|
|52 Week Range||306.86 - 496.92|
|PE Ratio (TTM)||73.76|
|Earnings Date||Jul 19, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||480.80|
Today's research coverage on WallStEquities.com is focused on four Medical Appliances and Equipment stocks, particularly, Boston Scientific Corp. (NYSE: BSX), Cesca Therapeutics Inc. (NASDAQ: KOOL), CHF Solutions Inc. (NASDAQ: CHFS), and Intuitive Surgical Inc. (NASDAQ: ISRG).
This analysis is intended to introduce important early concepts to people who are starting to invest and want to better understand how you can grow your money by investing inRead More...
Walgreens Boots' (WBA) consistent sales rise in the Retail Pharmacy International business is encouraging. Moreover, the company steadily gains traction from a slew of strategic deals.
Here we analyze how Medical Mechatronics is creating new opportunities in MedTech for investors who are keen on putting their money in the healthcare space for longer-term gains.
Medtronic's (MDT) receipt of FDA approval for 200mm and 250mm lengths of the IN.PACT Admiral Drug-Coated Balloon (DCB) is expected to boost the top line.
NEW YORK, June 18, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Antero ...
Express Scripts' (ESRX) loss of major customers, downbeat 2018 earnings guidance and selling of shares to Cigna make it lower its credibility as an investment pick.
Unsurprisingly, retail investors from around the globe are looking for ways to profit from this macro-level trend, and for many, the answer seems to lie in niche exchange-traded products. In this article, we take a look at the chart patterns that have started to appear throughout this dynamic sector and try to determine how traders will position themselves over the weeks and months ahead. Investors seeking to gain exposure to the rapidly growing area of robotics, automation and artificial intelligence may want to consider the Global Robotics and Automation Index ETF.
NEW YORK, June 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Neogen ...
Intuitive Surgical is about to face a lot more competition as Medtronic, Google, J&J and others roll out robotic surgery systems. But analysts see plenty of room for industry growth. Patients and investors should benefit.
In this article, I will take a quick look at Intuitive Surgical Inc’s (NASDAQ:ISRG) recent ownership structure – an unconventional investing subject, but an important one. A company’s ownership structureRead More...
CVS Health (CVS) significantly advances more than halfway through its 2019 renewals. Also, strong year-over-year Retail/LTC comparisons are encouraging.
Corindus Vascular Robotics (CVRS) saw a big move last session, as its shares jumped more than 14% on the day, amid huge volumes.
Exchange traded fund investors should future-proof portfolios with disruptive technologies. On the recent webcast, Behind the Machines: Investing in Robotics from a Research Perspective, Jeremie Capron, Director of Research for ROBO Global, said that the robotics and artificial intelligence industry is set on an exponential growth path. Expensive industrial robots were first introduced exclusively to auto manufacturers in the 1960s, and by today, the robotics, automation and artificial intelligence industry has grown to over $200 billion.
Genomic Health (GHDX) gains ground on promising reimbursement prospects for its Oncotype DX breast cancer test and solid international scenario.
It is pretty difficult for investors to choose from MedTech bigwigs Abiomed (ABMD) and Varian Medical (VAR) as both the companies are riding on solid estimate revision and other developments.
Varian (VAR) will demonstrate four brachytherapy solutions in the American Brachytherapy Society Annual Meeting in San Francisco.
STERIS' (STE) strong organic growth across specialty services, life sciences and applied sterilization segments raises optimism on the stock.